Nanexa AB (NANEXA)

Currency in SEK
3.4300
+0.0800(+2.39%)
Closed·
NANEXA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.28003.5600
52 wk Range
1.40005.0000
Key Statistics
Prev. Close
3.35
Open
3.405
Day's Range
3.28-3.56
52 wk Range
1.4-5
Volume
1.15M
Average Volume (3m)
617.73K
1-Year Change
116.6882%
Book Value / Share
0.64
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NANEXA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
30/04/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Nanexa (NANEXA) Income Statement & Profits

Compare NANEXA to Peers and Sector

Metrics to compare
NANEXA
Peers
Sector
Relationship
P/E Ratio
−49.6x−49.4x−0.5x
PEG Ratio
−0.820.700.00
Price/Book
5.6x3.9x2.6x
Price / LTM Sales
10.1x1.1x3.2x
Upside (Analyst Target)
-0.0%48.8%
Fair Value Upside
Unlock−25.2%6.9%Unlock

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that has completed Phase I trial for the treatment of type 2 diabetes; NEX-18, a drug from azacitidine to treat myelodysplastic syndrome; and NEX-20, a drug from lenalidomide for the treatment of multiple myeloma. The company has collaborations with Novo Nordisk to evaluate PharmaShell technology; and Moderna for the development of pharmaceutical products with active substances. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.

People Also Watch

3.110
SPRINT
-3.42%
1.10
NXTCL
-4.36%
7.50
ARCOMA
+0.81%
3.64
CFISH
+4.00%

FAQ

What Is the Nanexa (Stockholm: NANEXA) Share Price Today?

The Nanexa stock price today is 3.4300 SEK.

What Stock Exchange Does Nanexa (NANEXA) Trade On?

Nanexa is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Nanexa?

The stock symbol (also called a 'ticker') for Nanexa is "NANEXA."

What Is the Current Nanexa Market Capitalisation?

As of today, Nanexa (Stockholm: NANEXA) market cap is 564.5300M SEK.

What Is Nanexa's (NANEXA) Earnings Per Share (TTM)?

The Nanexa EPS is currently -0.0730 (Trailing Twelve Months).

When Is the Next Nanexa Earnings Date?

Nanexa's next earnings report will be released on 30/04/2026.

Is NANEXA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Nanexa moving averages and other technical indicators, the daily buy/sell signal for NANEXA stock is Strong Sell.

How Many Times Has Nanexa Stock Split?

Nanexa has split 4 times. (See the NANEXA stock split history page for full effective split date and price information.)

How Many Employees Does Nanexa Have?

Nanexa has 15 employees, based on their latest Companies House report.

What is the current trading status of Nanexa (Stockholm: NANEXA)?

As of 01/05/2026, Nanexa (NANEXA) is trading at a share price of 3.4300 SEK, with a previous close of 3.3500 SEK. The stock has fluctuated within a day range of 3.2800 SEK to 3.5600 SEK, while its 52-week range spans from 1.4000 SEK to 5.0000 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.